New cancer drug enters first human testing
Disease control
Not yet recruiting
This is the first human study of an experimental cancer drug called BGM-2121. Researchers will test it in 35 adults with advanced solid tumors who have already tried standard treatments. The main goals are to find the safest dose and see how the body handles the drug, while also …
Phase: PHASE1 • Sponsor: BioGate Precision Medicine Corp. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC